KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Common Equity (2016 - 2025)

Historic Common Equity for Teladoc Health (TDOC) over the last 13 years, with Q3 2025 value amounting to $1.4 billion.

  • Teladoc Health's Common Equity fell 766.64% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 766.64%. This contributed to the annual value of $1.5 billion for FY2024, which is 3589.72% down from last year.
  • According to the latest figures from Q3 2025, Teladoc Health's Common Equity is $1.4 billion, which was down 766.64% from $1.4 billion recorded in Q2 2025.
  • Teladoc Health's Common Equity's 5-year high stood at $16.0 billion during Q4 2021, with a 5-year trough of $1.4 billion in Q3 2025.
  • For the 5-year period, Teladoc Health's Common Equity averaged around $5.7 billion, with its median value being $2.3 billion (2023).
  • As far as peak fluctuations go, Teladoc Health's Common Equity surged by 148266.97% in 2021, and later plummeted by 8561.77% in 2022.
  • Over the past 5 years, Teladoc Health's Common Equity (Quarter) stood at $16.0 billion in 2021, then tumbled by 85.62% to $2.3 billion in 2022, then grew by 0.79% to $2.3 billion in 2023, then crashed by 35.9% to $1.5 billion in 2024, then fell by 6.64% to $1.4 billion in 2025.
  • Its Common Equity was $1.4 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.4 billion in Q1 2025.